Andrew Shapiro, DPM
Podiatrist · Valley Stream, NYNPI 1215019161
Payments from drug & device makers
Across 41 payments — averaging $58.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$502
- Integra Lifesciences Corporation$340
- Medtronic$153
- Nevro Corp.$149
- Smith+Nephew$146
- Amgen$143
- plus $956 from 20 others
What the payments were for
- Food & beverage$2,387100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 4 | $502 |
| Integra Lifesciences Corporation | 4 | $340 |
| Medtronic | 1 | $153 |
| Nevro Corp. | 1 | $149 |
| Smith+Nephew | 1 | $146 |
| Amgen(2 entities) | 2 | $143 |
| Stryker | 1 | $143 |
| AbbVie | 1 | $122 |
| Averitas Pharma Inc. | 2 | $111 |
| Biocomposites Inc | 1 | $100 |
| Kowa Pharmaceuticals America, Inc. | 3 | $79 |
| Sandoz | 3 | $54 |
| Zyla Life Sciences, Inc. | 3 | $47 |
| Johnson & Johnson | 1 | $45 |
| Alfasigma USA, Inc. | 2 | $38 |
| Orthofix Medical, Inc. | 1 | $28 |
| Treace Medical Concepts, Inc. | 1 | $24 |
| Focal Therapeutics, Inc. | 1 | $22 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Dynasplint Systems Inc. | 1 | $20 |
| Bioventus LLC | 1 | $19 |
| Advanced Oxygen Therapy Inc. | 1 | $19 |
| Assertio Therapeutics, Inc. | 1 | $18 |
| Sebela Pharmaceuticals Inc. | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Iroko Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$763
- Kerecis Omega3 Marigen$562
- Kerecis GraftGuide$191
- Senza$149
- GRAFIX PL$146
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$145
- CADENCE ANKLE REPLACEMENT SYSTEM$145
- HALLU-LOCK$145
- PANTA NAIL$145
- TOTAL FOOT SYSTEM$145
- CARTIVA$143
- Kerecis Omega3 SurgiClose$140
- KRYSTEXXA$125
- DALVANCE$122
- Stimulan$100
How this compares
$2,387 in reported general payments places this provider in the 75th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 92 | $2,016 |
| Ciclopirox | 40 | $841 |
| Ammonium Lactate | 58 | $701 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $456 |
| Betamethasone Valerate | 12 | $281 |
| Mupirocin | 13 | $96 |
| Cephalexin | 13 | $51 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Valley Stream
- Russell CaprioliValley Stream$8K
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Elvis DanneNew York$35K
- Adam CirlincioneGlen Cove$31K
- Jude ViolanteNiagara Falls$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.